Meda's Skr26bn loan syndication due before year end
Swedish pharmaceutical company Meda will syndicate out the remaining Skr26bn (€2.83bn) of its bridge loan for its acquisition of Italian consumer healthcare firm Rottapharm Madaus before the end of the year, a banker at one of the arrangers has said.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts
